Parand Darou Showcases Its Excellence in Pharmaceutical Exports

Parand Darou has demonstrated remarkable achievements in exports, securing a prominent position in the national pharmaceutical industry in 2024. Despite its relatively short history in the export sector, the company has achieved significant successes through its commitment to quality and innovation. In the past year, Parand Darou’s special export efforts earned it the second place among major pharmaceutical manufacturers in the country in terms of positive export balance and the top position among producers of active pharmaceutical ingredients in the country. In the foreign exchange balance index, Parand Darou has surpassed established pharmaceutical exporters such as Synajon, Exir, and Temad. Achieving these rankings is both an honor and a major contribution to the national pharmaceutical industry.

These successes reflect the tireless efforts of the Parand Darou team and its commitment to enhancing the quality of pharmaceutical products. Engineer Hamid Reza Alipour, CEO of Parand Darou, stated: “From the very beginning, we believed that with trust in God, reliance on research and development, adherence to international standards, and persistence in export planning, we could achieve great success. These achievements are the result of teamwork and the efforts of all our dedicated and skilled colleagues at Parand Darou.”

Parand Darou continues to strive to enhance its position in international markets and increase its export share. The company, with its quality-focused product development strategies, export-oriented market expansion, and profit-optimizing production plans, is optimistic about achieving greater success this year, which is dedicated to “Production Leap with People’s Participation.”

We believe that the key to enduring, dynamic, and flourishing success lies in conquering new export heights and hope to continuously improve in this field “better than yesterday.” “In hopes of a proud and triumphant Iran.”